| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 4,144 | 10,216 | ||
| Contract asset | 0 | 0 | ||
| Marketable securities | 0 | 0 | ||
| Prepaid expenses and other current assets | 811 | 857 | ||
| Total current assets | 4,955 | 11,073 | ||
| Property and equipment, net | 922 | 1,144 | ||
| Operating lease right-of-use asset | 4,017 | 4,388 | ||
| Other assets | 245 | 293 | ||
| Total assets | 10,139 | 16,898 | ||
| Accounts payable | 2,467 | 1,798 | ||
| Accrued expenses and other current liabilities | 2,091 | 2,636 | ||
| Current portion of long-term debt | 13,537 | 15,000 | ||
| Current portion of operating lease liability | 1,049 | 1,189 | ||
| Total current liabilities | 19,144 | 20,623 | ||
| Long-term debt, less current portion | 0 | 2,229 | ||
| Operating lease liability, less current portion | 2,968 | 3,199 | ||
| Total liabilities | 22,112 | 26,051 | ||
| Common stock, value-Common Class A | 4 | 3 | ||
| Common stock, value-Common Class B | 2 | 2 | ||
| Common stock, value-Common Class C | 0 | 0 | ||
| Additional paid-in capital | 114,406 | 111,280 | ||
| Accumulated other comprehensive gain | 3 | 3 | ||
| Accumulated deficit | -122,275 | -116,863 | ||
| Total stockholders' (deficit)/equity attributable to rani therapeutics holdings, inc | -7,860 | -5,575 | ||
| Non-controlling interest | -4,113 | -3,578 | ||
| Total stockholders' (deficit)/equity | -11,973 | -9,153 | ||
| Total liabilities and stockholders' equity | 10,139 | 16,898 | ||
Rani Therapeutics Holdings, Inc. (RANI)
Rani Therapeutics Holdings, Inc. (RANI)